Nkarta to participate at upcoming investor conference

South san francisco, calif., aug. 03, 2023 (globe newswire) -- nkarta, inc. (nasdaq: nktx), a biopharmaceutical company developing engineered natural killer (nk) cell therapies, today announced its participation at an upcoming investor conference:

NKTX Ratings Summary

NKTX Quant Ranking